Medicare to cover monoclonal antibody drugs for
COVID-19
The CMS announced that Medicare will cover out-of-pocket costs for
Eli Lilly and Co.'s bamlanivimab and other monoclonal antibody drugs for
COVID-19 for the duration of the public health emergency. Medicare will pay for
the infusion and not for the drugs when they are provided for free to health
care providers, CMS said.
Full Story: Healthcare
Finance (11/11)
No comments:
Post a Comment